On October 3, ImmuPharma plc informed that a Nomination Committee has been appointed to consist of the following persons who together represent 7.52% of the number of shares and votes in the company as of September 30, 2023: Sara Ek, Carl Borrebaeck and Mats Leifland, Sara Ek being appointed Chair of the nomination Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.165 GBX | +6.91% | +13.95% | +29.87% |
29/04 | Immunovia Announces the Appointment of Lisa Fordas as Clinical Laboratory Director | CI |
02/04 | Immupharma jumps amid new IP strategy for P140 technology platform | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+29.87% | 10.55M | |
+18.53% | 47.02B | |
+48.77% | 41.86B | |
+1.39% | 41.76B | |
-4.27% | 28.8B | |
+11.32% | 26.05B | |
-21.16% | 19.15B | |
+4.69% | 12.55B | |
+27.68% | 12.34B | |
-3.57% | 11.82B |
- Stock Market
- Equities
- IMM Stock
- News ImmuPharma plc
- ImmuPharma plc Announces Executive Appointments